Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 26.30% vs -37.31% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 11.85% vs -6.64% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 19.90% vs -29.69% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 1.61% vs -3.21% in Mar 2025
Compare Balance Sheet Results of Link Pharma Chem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.44
4.20
0.24
5.71%
Share Warrants & Outstandings
Total Reserve
8.35
9.86
-1.51
-15.31%
Shareholder's Funds
12.79
14.06
-1.27
-9.03%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.70
0.00
0.70
0.00%
Secured Loans
0.70
0.00
0.70
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.16
0.01
-0.17
-1,700.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.24
0.00
0.24
0.00%
Total Non-Current Liabilities
0.77
0.01
0.76
7,600.00%
Current Liabilities
Trade Payables
3.25
0.40
2.85
712.50%
Other Current Liabilities
0.88
0.34
0.54
158.82%
Short Term Borrowings
6.61
2.85
3.76
131.93%
Short Term Provisions
0.50
0.00
0.50
0.00%
Total Current Liabilities
11.24
3.59
7.65
213.09%
Total Liabilities
24.81
17.67
7.14
40.41%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
18.01
15.69
2.32
14.79%
Less: Accumulated Depreciation
7.63
10.10
-2.47
-24.46%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.38
5.58
4.80
86.02%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.03
-0.03
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.47
2.26
0.21
9.29%
Long Term Loans & Advances
0.58
0.08
0.50
625.00%
Other Non Current Assets
0.04
0.39
-0.35
-89.74%
Total Non-Current Assets
13.46
8.34
5.12
61.39%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
5.02
5.00
0.02
0.40%
Sundry Debtors
5.28
4.04
1.24
30.69%
Cash and Bank
0.63
0.07
0.56
800.00%
Other Current Assets
0.07
0.10
-0.03
-30.00%
Short Term Loans and Advances
0.34
0.11
0.23
209.09%
Total Current Assets
11.34
9.32
2.02
21.67%
Net Current Assets (Including Current Investments)
0.10
5.73
-5.63
-98.25%
Total Current Assets Excluding Current Investments
11.34
9.32
2.02
21.67%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
24.81
17.67
7.14
40.41%
Contingent Liabilities
1.61
0.00
1.61
0.00%
Total Debt
7.30
2.85
4.45
156.14%
Book Value per share (adjusted)
28.80
33.49
-4.69
-14.00%
Annual - Borrowings
Borrowings 7.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 26.30% vs -37.31% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.85% vs -6.64% in Mar 2025
Annual - Investments
Investments 2.47 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.90% vs -29.69% in Mar 2025
Annual - Current Assets
Current Assets 11.34 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.61% vs -3.21% in Mar 2025
